BiVictriX Therapeutics PLC identifies a development lead for its BVX001 cancer programme

Card image cap

BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF), an emerging biotechnology company applying a novel approach to develop next-generation cancer therapies...

Related Keywords

, Bivictrix Therapeutics , Antibody Drug Conjugates , Acute Myeloid Leukaemia , Tiffany Thorn ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.